Atlas Trials

Peripheral T-cell Lymphoma (PTCL)

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Peripheral T-cell Lymphoma (PTCL)

RecordFirmDate
Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors (NCT05225584)Kymera Therapeutics, Inc.2022-05-19
Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients (NCT04696705)Institute of Hematology & Blood Diseases Hospital, China2020-12-31
Evaluating the Effectiveness of Decitabine With Gemcitabine, Oxaliplatin for Relapsed/Refractory Peripheral T-cell Lymphoma (NCT06941688)Seoul National University Hospital2020-11-13
A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies (NCT04072458)Bio-Path Holdings, Inc.2020-11-05
Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL) (NCT02689453)National Cancer Institute (NCI)2017-01-19
A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL) (NCT02594267)Acrotech Biopharma Inc.2015-11-10
A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of Depsipeptide (FK228) in Patients That Have Completed a Prior Clinical Study With Depsipeptide. (NCT00299351)Royal Marsden NHS Foundation Trust

Track Peripheral T-cell Lymphoma (PTCL) automatically

Every clearance here is in the API, with alerts when new ones post.